# reload+after+2024-01-20 21:31:57.734966
address1§30 Hudson Street
address2§Floor 33
city§Jersey City
state§NJ
zip§07302
country§United States
phone§551 430 6900
website§https://www.organon.com
industry§Drug Manufacturers—General
sector§Healthcare
longBusinessSummary§Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive; Nuvaring, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
fullTimeEmployees§10000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Kevin  Ali', 'age': 63, 'title': 'CEO & Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 3963940, 'exercisedValue': 0, 'unexercisedValue': 119103}, {'maxAge': 1, 'name': 'Mr. Matthew M. Walsh', 'age': 56, 'title': 'Executive VP & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1841675, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susanne Gabriele Fiedler', 'age': 55, 'title': 'Executive VP & Chief Commercial Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1443710, 'exercisedValue': 0, 'unexercisedValue': 73585}, {'maxAge': 1, 'name': 'Mr. Joseph T. Morrissey Jr.', 'age': 58, 'title': 'Executive VP and Head of Manufacturing & Supply', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 1536104, 'exercisedValue': 0, 'unexercisedValue': 138636}, {'maxAge': 1, 'name': 'Ms. Rachel A. Stahler', 'age': 47, 'title': 'Executive VP & Chief Information Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Halchak', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kirke  Weaver', 'age': 50, 'title': 'Executive VP, General Counsel & Corporate Secretary', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Aaron  Falcione', 'age': 52, 'title': 'Executive VP & Chief Human Resources Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vittorio  Nisita', 'age': 55, 'title': 'Executive VP & Head of Global Business Services', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Geralyn S. Ritter', 'age': 54, 'title': 'Executive Vice President of Corporate Affairs, Sustainability & ESG', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§1
compensationRisk§2
shareHolderRightsRisk§2
overallRisk§1
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§1.12
dividendYield§0.0777
exDividendDate§1699574400
payoutRatio§0.4912
beta§0.738
priceToSalesTrailing12Months§0.5989077
currency§USD
dateShortInterest§1702598400
forwardEps§4.27
pegRatio§-0.67
exchange§NYQ
quoteType§EQUITY
shortName§Organon & Co.
longName§Organon & Co.
firstTradeDateEpochUtc§1620999000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§1bf1386a-e8ec-3070-9c74-cd495b950fc0
gmtOffSetMilliseconds§-18000000
targetHighPrice§27.0
targetLowPrice§12.0
targetMeanPrice§21.13
targetMedianPrice§22.0
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§8
quickRatio§0.831
earningsGrowth§-0.745
grossMargins§0.60699004
ebitdaMargins§0.24927
trailingPegRatio§None
